DATE ADDED TO CATALOG	PUBMEDID	FIRST AUTHOR	DATE	JOURNAL	LINK	STUDY	DISEASE/TRAIT	INITIAL SAMPLE SIZE	REPLICATION SAMPLE SIZE	REGION	CHR_ID	CHR_POS	REPORTED GENE(S)	MAPPED_GENE	UPSTREAM_GENE_ID	DOWNSTREAM_GENE_ID	SNP_GENE_IDS	UPSTREAM_GENE_DISTANCE	DOWNSTREAM_GENE_DISTANCE	STRONGEST SNP-RISK ALLELE	SNPS	MERGED	SNP_ID_CURRENT	CONTEXT	INTERGENIC	RISK ALLELE FREQUENCY	P-VALUE	PVALUE_MLOG	P-VALUE (TEXT)	OR or BETA	95% CI (TEXT)	PLATFORM [SNPS PASSING QC]	CNV	MAPPED_TRAIT	MAPPED_TRAIT_URI	STUDY ACCESSION	GENOTYPING TECHNOLOGY
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	2q22.3	2	146957758	PABPC1P2	AC062032.1 - AC018678.1	ENSG00000227902	ENSG00000287847		59540	192949	rs1606812-?	rs1606812	0	1606812	intergenic_variant	1	NR	3E-7	6.522878745280337	(AA)	11.5	[7.19-15.81] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	response to sulfonylurea, QT interval	http://www.ebi.ac.uk/efo/EFO_0007922, http://www.ebi.ac.uk/efo/EFO_0004682	GCST004031	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QRS interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	11p14.3	11	25778731	intergenic	LINC02699			ENSG00000254456			rs10767455-?	rs10767455	0	10767455	intron_variant	0	NR	4E-7	6.3979400086720375	(AA)	2.1	[1.32-2.88] ms increase	Affymetrix, Illumina [~ 2500000] (imputed)	N	QRS duration, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0005055, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004033	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	5q23.1	5	119576903	HSD17B4, FAM170A	HSD17B4			ENSG00000133835			rs7726558-?	rs7726558	0	7726558	intron_variant	0	NR	4E-7	6.3979400086720375	(AA)	6.2	[3.85-8.55] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	response to sulfonylurea, QT interval	http://www.ebi.ac.uk/efo/EFO_0007922, http://www.ebi.ac.uk/efo/EFO_0004682	GCST004031	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QRS interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	11q24.2	11	127807979	intergenic	AP003532.1 - AP001000.1	ENSG00000254591	ENSG00000254612		150102	132934	rs985292-?	rs985292	0	985292	intergenic_variant	1	NR	1E-6	6.0	(AA)	2.4	[1.42-3.38] ms increase	Affymetrix, Illumina [~ 2500000] (imputed)	N	QRS duration, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0005055, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004033	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	4p15.1	4	32375105	intergenic	LINC02353 - AC116611.1	ENSG00000251329	ENSG00000286784		21885	208750	rs17081313-?	rs17081313	0	17081313	intergenic_variant	1	NR	2E-7	6.698970004336019		11.2	[7.08-15.32] ms increase	Affymetrix, Illumina [~ 2500000] (imputed)	N	response to sulfonylurea, QT interval	http://www.ebi.ac.uk/efo/EFO_0007922, http://www.ebi.ac.uk/efo/EFO_0004682	GCST004031	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QRS interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	4q21.23	4	83203287	PLAC8, COQ2	PLAC8 - AC114781.2	ENSG00000145287	ENSG00000250057		66212	30225	rs4591595-?	rs4591595	0	4591595	intergenic_variant	1	NR	3E-7	6.522878745280337	(EA)	2.8	[1.62-3.98] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	QRS duration, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0005055, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004033	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QRS interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	18q22.3	18	73269323	LOC400655	AC079062.1 - LINC02582	ENSG00000263711	ENSG00000261780		4843	55618	rs4362469-?	rs4362469	0	4362469	intergenic_variant	1	NR	7E-7	6.154901959985743	(EA)	4.8	[2.84-6.76] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	QRS duration, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0005055, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004033	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QRS interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	20q11.22	20	35385096	UQCC	UQCC1			ENSG00000101019			rs4911179-?	rs4911179	0	4911179	intron_variant	0	NR	8E-8	7.096910013008056	(EA)	1.7	[1.11-2.29] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	QRS duration, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0005055, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004033	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QRS interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	14q21.1	14	42709204	intergenic	AL442163.1 - AL356800.1	ENSG00000258394	ENSG00000258934		5549	98174	rs1777084-?	rs1777084	0	1777084	intergenic_variant	1	NR	1E-6	6.0	(Hispanic/Latino)	3.3	[1.93-4.67] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	QRS duration, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0005055, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004033	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QRS interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	8p23.2	8	4328031	CSMD1	CSMD1, AC027251.1			ENSG00000183117, ENSG00000286934			rs2134953-?	rs2134953	0	2134953	non_coding_transcript_exon_variant	0	NR	8E-8	7.096910013008056		7.8	[5.06-10.54] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	QRS duration, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0005055, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004033	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QRS interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	9p22.2	9	17346857	CNTLN	CNTLN			ENSG00000044459			rs7861565-?	rs7861565	0	7861565	intron_variant	0	NR	2E-7	6.698970004336019		3.7	[2.33-5.07] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	QRS duration, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0005055, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004033	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	JT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	5q23.1	5	119573311	FAM170A, HSD17B4	HSD17B4			ENSG00000133835			rs1388107-?	rs1388107	0	1388107	intron_variant	0	NR	5E-7	6.301029995663981	(AA)	6.2	[3.85-8.55] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	JT interval, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0007885, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004032	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	JT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	13q13.3	13	35792945	MIR548F5	DCLK1			ENSG00000133083			rs2182486-?	rs2182486	0	2182486	intron_variant	0	NR	1E-7	7.0	(AA)	13.3	[8.4-18.2] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	JT interval, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0007885, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004032	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	JT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	3q13.32	3	118240655	LOC105374060	AC068633.1			ENSG00000243276			rs9853921-?	rs9853921	0	9853921	intron_variant	0	NR	8E-7	6.096910013008056		2.3	[1.32-3.28] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	JT interval, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0007885, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004032	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	JT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	5q22.3	5	114520357	KCNN2	AC010230.1			ENSG00000246316			rs624896-?	rs624896	0	624896	intron_variant	0	NR	9E-7	6.045757490560675		6.0	[3.65-8.35] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	JT interval, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0007885, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004032	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QRS interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	2p13.2	2	71324491	ZNF638, PAIP2B	ZNF638			ENSG00000075292			rs7595140-?	rs7595140	0	7595140	intron_variant	0	NR	4E-8	7.3979400086720375	(EA)	5.7	[3.74-7.66] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	QRS duration, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0005055, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004033	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	JT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	7q31.1	7	109123612	THAP5, PNPLA8	BUB3P1 - AC002386.1	ENSG00000227968	ENSG00000230941		128583	198708	rs17156495-?	rs17156495	0	17156495	intergenic_variant	1	NR	5E-7	6.301029995663981		8.5	[5.17-11.83] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	JT interval, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0007885, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004032	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QRS interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	7p11.2	7	55327697	LANCL2, ELDR	CALM1P2 - AC073347.1	ENSG00000230564	ENSG00000230936		67441	14619	rs1997103-?	rs1997103	0	1997103	intergenic_variant	1	NR	6E-8	7.221848749616356	(AA)	9.0	[5.67-12.33] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	QRS duration, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0005055, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004033	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	JT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	11q14.2	11	86614845	ME3	ME3, AP001831.1			ENSG00000151376, ENSG00000254733			rs17211409-?	rs17211409	0	17211409	intron_variant	0	NR	6E-8	7.221848749616356	(Hispanic/Latino)	11.6	[7.48-15.72] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	JT interval, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0007885, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004032	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	JT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	14q24.3	14	78425799	NRXN3	NRXN3			ENSG00000021645			rs17107548-?	rs17107548	0	17107548	intron_variant	0	NR	1E-6	6.0	(Hispanic/Latino)	6.6	[4.05-9.15] ms increase	Affymetrix, Illumina [~ 2500000] (imputed)	N	JT interval, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0007885, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004032	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	JT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	1p31.3	1	61648730	TM2D1, NFIA	AC099791.4 - AC099791.1	ENSG00000287224	ENSG00000223920		58826	5464	rs1890262-?	rs1890262	0	1890262	intergenic_variant	1	NR	2E-8	7.698970004336019	(EA)	14.9	[9.8-20] ms increase	Affymetrix, Illumina [~ 2500000] (imputed)	N	JT interval, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0007885, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004032	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	JT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	2q32.2	2	190967538	GLS, STAT1	STAT1			ENSG00000115415			rs12468579-?	rs12468579	0	12468579	intron_variant	0	NR	5E-8	7.301029995663981	(AA)	4.1	[2.53-5.67] ms increase	Affymetrix, Illumina [~ 2500000] (imputed)	N	JT interval, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0007885, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004032	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	JT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	3q26.1	3	162558617	intergenic	TOMM22P6 - AC128716.1	ENSG00000241874	ENSG00000243044		71668	43010	rs1478173-?	rs1478173	0	1478173	intergenic_variant	1	NR	1E-12	12.0	(AA)	15.0	[10.88-19.12] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	JT interval, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0007885, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004032	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	JT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	4q34.3	4	181714136	TENM3	AC084741.1 - TEMN3-AS1	ENSG00000287948	ENSG00000251336		13994	105883	rs17281245-?	rs17281245	0	17281245	intergenic_variant	1	NR	5E-9	8.301029995663981	(AA)	8.8	[5.86-11.74] ms increase	Affymetrix, Illumina [~ 2500000] (imputed)	N	JT interval, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0007885, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004032	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	JT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	5p14.1	5	28750200	LSP1P3	AC008825.1			ENSG00000250453			rs7713675-?	rs7713675	0	7713675	intron_variant	0	NR	1E-8	8.0	(AA)	12.2	[8.08-16.32] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	JT interval, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0007885, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004032	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	2q33.1	2	200139114	SPATS2L, TYW5	AC004464.1 - SPATS2L	ENSG00000287027	ENSG00000196141		39089	166767	rs1106399-?	rs1106399	0	1106399	regulatory_region_variant	1	NR	3E-7	6.522878745280337	(AA)	10.5	[6.58-14.42] ms increase	Affymetrix, Illumina [~ 2500000] (imputed)	N	response to sulfonylurea, QT interval	http://www.ebi.ac.uk/efo/EFO_0007922, http://www.ebi.ac.uk/efo/EFO_0004682	GCST004031	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QRS interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	6q15	6	89685297	MDN1	MDN1			ENSG00000112159			rs10484885-?	rs10484885	0	10484885	intron_variant	0	NR	9E-7	6.045757490560675	(AA)	3.5	[2.13-4.87] ms increase	Affymetrix, Illumina [~ 2500000] (imputed)	N	QRS duration, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0005055, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004033	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	2q14.3	2	122651367	intergenic	AC011246.1			ENSG00000286481			rs1439840-?	rs1439840	0	1439840	intron_variant	0	NR	7E-7	6.154901959985743		4.7	[2.74-6.66] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	response to sulfonylurea, QT interval	http://www.ebi.ac.uk/efo/EFO_0007922, http://www.ebi.ac.uk/efo/EFO_0004682	GCST004031	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QRS interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	3p14.1	3	68906333	FAM19A4	TAFA4			ENSG00000163377			rs4855537-?	rs4855537	0	4855537	intron_variant	0	NR	1E-6	6.0	(AA)	4.6	[2.84-6.36] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	QRS duration, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0005055, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004033	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	2p24.2	2	18451319	NT5C1B, KCNS3	AC079148.3			ENSG00000287881			rs6718130-?	rs6718130	0	6718130	intron_variant	0	NR	8E-8	7.096910013008056	(EA)	9.1	[5.77-12.43] ms increase	Affymetrix, Illumina [~ 2500000] (imputed)	N	response to sulfonylurea, QT interval	http://www.ebi.ac.uk/efo/EFO_0007922, http://www.ebi.ac.uk/efo/EFO_0004682	GCST004031	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	20p11.23	20	19291566	SLC24A3	SLC24A3			ENSG00000185052			rs6035275-?	rs6035275	0	6035275	intron_variant	0	NR	1E-7	7.0	(EA)	12.0	[7.69-16.31] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	response to sulfonylurea, QT interval	http://www.ebi.ac.uk/efo/EFO_0007922, http://www.ebi.ac.uk/efo/EFO_0004682	GCST004031	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	3p14.2	3	62548760	CADPS	CADPS			ENSG00000163618			rs17639063-?	rs17639063	0	17639063	intron_variant	0	NR	3E-7	6.522878745280337	(Hispanic/Latino)	9.7	[5.98-13.42] ms increase	Affymetrix, Illumina [~ 2500000] (imputed)	N	response to sulfonylurea, QT interval	http://www.ebi.ac.uk/efo/EFO_0007922, http://www.ebi.ac.uk/efo/EFO_0004682	GCST004031	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	18q11.2	18	25825224	SS18	RN7SL97P - AC027229.1	ENSG00000242216	ENSG00000264193		6692	127992	rs9966832-?	rs9966832	0	9966832	regulatory_region_variant	1	NR	2E-8	7.698970004336019	(EA)	10.4	[6.68-14.12] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	response to sulfonylurea, QT interval	http://www.ebi.ac.uk/efo/EFO_0007922, http://www.ebi.ac.uk/efo/EFO_0004682	GCST004031	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	5q34	5	165976741	intergenic	AC008489.1 - RPL7P20	ENSG00000253946	ENSG00000254252		71133	51826	rs830233-?	rs830233	0	830233	intergenic_variant	1	NR	3E-12	11.522878745280337	(AA)	16.3	[11.79-20.81] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	response to sulfonylurea, QT interval	http://www.ebi.ac.uk/efo/EFO_0007922, http://www.ebi.ac.uk/efo/EFO_0004682	GCST004031	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	1p31.3	1	61648730	TM2D1, NFIA	AC099791.4 - AC099791.1	ENSG00000287224	ENSG00000223920		58826	5464	rs1890262-?	rs1890262	0	1890262	intergenic_variant	1	NR	8E-7	6.096910013008056	(EA)	13.8	[8.31-19.29] ms increase	Affymetrix, Illumina [~ 2500000] (imputed)	N	response to sulfonylurea, QT interval	http://www.ebi.ac.uk/efo/EFO_0007922, http://www.ebi.ac.uk/efo/EFO_0004682	GCST004031	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	1q24.3	1	172384331	DNM3	PIGC, DNM3			ENSG00000135845, ENSG00000197959			rs12132562-?	rs12132562	0	12132562	intron_variant	0	NR	4E-7	6.3979400086720375	(AA)	8.5	[5.17-11.83] ms increase	Affymetrix, Illumina [~ 2500000] (imputed)	N	response to sulfonylurea, QT interval	http://www.ebi.ac.uk/efo/EFO_0007922, http://www.ebi.ac.uk/efo/EFO_0004682	GCST004031	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QRS interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	6p12.1	6	54389791	TINAG	TINAG			ENSG00000137251			rs3736352-?	rs3736352	0	3736352	missense_variant	0	NR	3E-7	6.522878745280337		2.7	[1.72-3.68] ms increase	Affymetrix, Illumina [~ 2500000] (imputed)	N	QRS duration, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0005055, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004033	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QRS interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	13q14.13	13	46267417	LRRC63	LRRC63			ENSG00000173988			rs10507540-?	rs10507540	0	10507540	intron_variant	0	NR	6E-8	7.221848749616356		2.2	[1.42-2.98] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	QRS duration, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0005055, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004033	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QRS interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	18q12.3	18	44442837	SETBP1	LINC01478			ENSG00000267337			rs1397988-?	rs1397988	0	1397988	intron_variant	0	NR	7E-7	6.154901959985743		1.6	[1.01-2.19] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	QRS duration, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0005055, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004033	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QRS interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	20q11.22	20	35320106	UQCC	UQCC1			ENSG00000101019			rs6088791-?	rs6088791	0	6088791	intron_variant	0	NR	8E-7	6.096910013008056		1.1	[0.71-1.49] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	QRS duration, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0005055, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004033	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	JT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	6p25.1	6	5478560	FARS2	FARS2			ENSG00000145982			rs200214-?	rs200214	0	200214	intron_variant	0	NR	4E-7	6.3979400086720375		3.6	[2.23-4.97] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	JT interval, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0007885, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004032	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QRS interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	9p22.2	9	17346857	CNTLN	CNTLN			ENSG00000044459			rs7861565-?	rs7861565	0	7861565	intron_variant	0	NR	6E-8	7.221848749616356	(AA)	4.0	[2.63-5.37] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	QRS duration, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0005055, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004033	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	JT interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	8q24.12	8	121285201	HAS2, SNTB1	AC068413.1 - RPL35AP19	ENSG00000253619	ENSG00000239872		165447	94936	rs16895033-?	rs16895033	0	16895033	intergenic_variant	1	NR	1E-6	6.0	(EA)	7.9	[4.76-11.04] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	JT interval, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0007885, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004032	Genome-wide genotyping array
2017-05-12	27958378	Floyd JS	2016-12-13	Pharmacogenomics J	www.ncbi.nlm.nih.gov/pubmed/27958378	Large-scale pharmacogenomic study of sulfonylureas and the QT, JT and QRS intervals: CHARGE Pharmacogenomics Working Group.	QRS interval (sulfonylurea treatment interaction)	2,095 European ancestry exposed individuals, 42,907 European ancestry unexposed individuals, 1,167 African American exposed individuals, 10,564 African American unexposed individuals, 794 Hispanic/Latino American exposed individuals, 14,330 Hispanic/Latino American unexposed individuals	NA	13q32.3	13	98775476	DOCK9, SLC15A1	SLC15A1 - DOCK9	ENSG00000088386	ENSG00000088387		22804	17953	rs12430683-?	rs12430683	0	12430683	intergenic_variant	1	NR	2E-7	6.698970004336019	(AA)	3.2	[2.02-4.38] ms decrease	Affymetrix, Illumina [~ 2500000] (imputed)	N	QRS duration, response to sulfonylurea	http://www.ebi.ac.uk/efo/EFO_0005055, http://www.ebi.ac.uk/efo/EFO_0007922	GCST004033	Genome-wide genotyping array
